174073-49-5

Basic information

• Product Name: Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 5-(bromomethyl)-1-[(2,6-difluorophenyl)methyl]-6-(4-nitrophenyl)-3-phen yl-
• CAS NO: 174073-49-5
• Molecular Formula: C26H16BrF2N3O4S
• Molecular Weight: 584.398
• Mol File: 174073-49-5.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 5-(bromomethyl)-1-[(2,6-difluorophenyl)methyl]-6-(4-nitrophenyl)-3-phen yl-(CAS DataBase Reference)
• NIST Chemistry Reference: Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 5-(bromomethyl)-1-[(2,6-difluorophenyl)methyl]-6-(4-nitrophenyl)-3-phen yl-(174073-49-5)
• EPA Substance Registry System: Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione, 5-(bromomethyl)-1-[(2,6-difluorophenyl)methyl]-6-(4-nitrophenyl)-3-phen yl-(174073-49-5)

Safety Data

• Hazardous Substances Data: 174073-49-5(Hazardous Substances Data)

Upstream product

• 103-71-9 phenyl isocyanate 
• 34241-39-9 azobisisobutyronitrile 
• 174073-19-9 1-(2,6-difluorobenzyl)-5-methyl-6-(4-nitrophenyl)-3-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione 
• 697-73-4 2,6-difluorobenzyl chloride 

Downstream Products

• 174071-70-6 5-(N-benzyl-N-methylaminomethyl)-1-(2,6-difluorobenzyl)-6-(4-nitrophenyl)-3-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione 
• 481049-97-2 5-(N-benzyl-N-methylaminomethyl)-1-(2,6-difluorobenzyl)-6-[4-[3-(2,4-dimethoxybenzyloxy)ureido]phenyl]-3-phenylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione 
• 481049-98-3 C₃₇H₃₃F₂N₅O₄S 
• 481049-99-4 C₃₈H₃₅F₂N₅O₄S 
• 481049-96-1 1-{4-[5-[(benzyl-methyl-amino)-methyl]-1-(2,6-difluoro-benzyl)-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydro-thieno[2,3-d]pyrimidin-6-yl]-phenyl}-3-isopropyl-urea 
• 308831-77-8 5-(N-benzyl-N-methylaminomethyl)-1-(2,6-difluorobenzyl)-6-[4-(3-hydroxyureido)phenyl]-3-phenylthieno[2,3-d]pyrimidine-2,4-(1H,3H)-dione 
• 308831-61-0 N-(4-(5-((benzyl(methyl)amino)methyl)-1-(2,6-difluorobenzyl)-1,2,3,4-tetrahydro-2,4-dioxo-3-phenylthieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea 
• 481049-94-9 5-(N-benzyl-N-methylaminomethyl)-1-(2,6-difluorobenzyl)-6-[4-(3-methylureido)phenyl]-3-phenylthieno[2,3-d]pyrimidine-2,4-(1H,3H)-dione 

Relevant articles and documents

PREMATURE OVULATION PREVENTIVE AGENT

The present invention provides a premature ovulation inhibitor for use in in vitro fertilization or embryo transfer process, which contains a nonpeptidic compound having a gonadotropin releasing hormone antagonistic action. The premature ovulation inhibitor for use in in vitro fertilization or embryo transfer process of the present invention is low toxic, permits oral administration, and has a superior inhibitory effect on premature ovulation in in vitro fertilization or embryo transfer process.

MEDICINAL SOLUTIONS

The present invention relates to a pharmaceutical solution containing a physiologically active non-peptide substance, an organic acid and a biocompatible organic solvent, and provides a pharmaceutical solution wherein a physiologically active non-peptide

SUSTAINED RELEASE COMPOSITIONS

A composition prepared by containing or blending a physiologically active non-peptide substance and a biodegradable polymer having two or more carboxylic groups at its end or a salt thereof features: (1) larger content of the physiologically active non-peptide substance can be contained, as well as release of the same can be controlled or accelerated, whereby secure pharmaceutical effect is achieved; (2) when the physiologically active non-peptide substance causes subcutaneous stimulation, an activity of canceling the stimulation by strongly acidic group at its end is expected; and (3) high glass transition point and high stability.